RILIMOGENE GALVACIREPVEC EXPRESSED PROSTATE-SPECIFIC ANTIGEN (I155L, N196Y)
UNII SWH9LGX9PA

Substance Identification & Data

This profile provides standardized clinical and technical data for Rilimogene Galvacirepvec Expressed Prostate-specific Antigen (i155l, N196y), uniquely identified by the FDA Unique Ingredient Identifier (UNII) SWH9LGX9PA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
SWH9LGX9PA
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
RILIMOGENE GALVACIREPVEC EXPRESSED PROSTATE-SPECIFIC ANTIGEN (I155L, N196Y)
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rilimogene Galvacirepvec Expressed Prostate-specific Antigen (i155l, N196y). Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

PROSTATE-SPECIFIC ANTIGEN (I155L, N196Y)
RILIMOGENE GALVACIREPVEC EXPRESSED PROSTATE-SPECIFIC ANTIGEN (I155L, N196Y)

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record